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Abstract
In recent years, matrix-assisted laser desorption-ionization time-of-ﬂight (MALDI-TOF) mass spectrometry (MS) has proved a rapid and
reliable method for the identiﬁcation of bacteria and yeasts that have already been isolated. The objective of this study was to evaluate this
technology as a routine method for the identiﬁcation of microorganisms directly from blood culture bottles (BCBs), before isolation, in a
large collection of samples. For this purpose, 1000 positive BCBs containing 1085 microorganisms have been analysed by conventional
phenotypic methods and by MALDI-TOF MS. Discrepancies have been resolved using molecular methods: the ampliﬁcation and sequencing
of the 16S rRNA gene or the Superoxide Dismutase gene (sodA) for streptococcal isolates. MALDI-TOF predicted a species- or genus-level
identiﬁcation of 81.4% of the analysed microorganisms. The analysis by episode yielded a complete identiﬁcation of 814 out of 1000 analysed
episodes (81.4%). MALDI-TOF identiﬁcation is available for clinicians within hours of a working shift, as oppose to 18 h later when
conventional identiﬁcation methods are performed. Moreover, although further improvement of sample preparation for polymicrobial
BCBs is required, the identiﬁcation of more than one pathogen in the same BCB provides a valuable indication of unexpected pathogens
when their presence may remain undetected in Gram staining. Implementation of MALDI-TOF identiﬁcation directly from the BCB provides
a rapid and reliable identiﬁcation of the causal pathogen within hours.
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Introduction
Rapid identiﬁcation of pathogens causing bloodstream infections
(BSIs) is probably the most critical test in the microbiology
laboratory [1] and may contribute to reducing the high levels
of morbidity and mortality associated with sepsis [2].
Available conventional techniques require culturing positive
blood culture bottles (BCBs) on agar media prior to the
identiﬁcation of the pathogen. These steps delay the ﬁnal
identiﬁcation, hampering the outcome and delaying correct
antibiotic treatment of the patient [3].
Moreover, molecular assays, such as PCR ampliﬁcation and
sequencing of the 16S rRNA gene or the superoxide dismutase
gene (sodA), have been implemented and widely used in the
microbiology laboratory for the identiﬁcation of atypical
microorganisms [4,5]. These PCR-based techniques provide
highly reliable results, although the time elapsed until a ﬁnal
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identiﬁcation is obtained does not allow a rapid and speciﬁc
treatment of the bacteraemic patient [6].
Recently, matrix-assisted laser desorption-ionization time-
of-ﬂight (MALDI-TOF) mass spectrometry (MS) has been
successfully implemented for the identiﬁcation of pathogens in
BCBs isolated on solid media [7]. Attempts to identify
microorganisms directly from BCBs are scarce [8,9] and
studies performed on a routine basis in a large collection of
clinical samples are lacking.
In this study, MALDI-TOFMS technology has been applied to
the rapid identiﬁcation of microorganisms directly from positive
BCBs within the routine of a busy microbiology laboratory of a
large teaching hospital. The impact of the shortened turnaround
time for a ﬁnal identiﬁcation of a pathogen has been evaluated by
episode and by microorganism.
Materials and Methods
Study settings
Our institution is a 1550-bed tertiary referral teaching hospital,
serving c. 750 000 inhabitants within the Madrid metropolitan
area. Our microbiology laboratory detects an average of 130
signiﬁcant bacteraemic episodes (SBEs) per month. From
August 2011 to January 2013, 1000 consecutive blood culture
bottles representing 1000 SBEs were tested with MALDI-TOF
MS technology.
Blood culture processing
All blood culture bottleswere processed on a BDBACTECTM FX
instrument (BectonDickinson, Franklin Lakes, NJ, USA). Bottles
were incubated at 35°C for 5 days. When the instrument
indicated that a bottle was positive, Gram staining was
performed and a drop from each positive bottle was cultured
on blood, chocolate and Brucella agar (Becton Dickinson) and
incubated at 35°C. A direct susceptibility test using the disk
diffusionmethodwas alsoperformedoneverypositiveBCB[10].
The isolates from the cultures were further identiﬁed by
phenotypical conventional methods: MicroScan panels (Micro-
Scan Systems, Siemens, Renton, WA, USA), API strips
(BioMerieux, Marcy l’Etoile, France) and biochemical tests.
A signiﬁcant bacteraemic episode was deﬁned as follows:
the presence of at least one signiﬁcant bacteria or yeast in one
or more blood culture bottles obtained within a week. Positive
SBEs separated by more than a week were considered as
different episodes.
MALDI-TOF mass spectrometry
MALDI-TOF settings. All BCBs were analysed by MALDI-TOF
MS, using a Microﬂex LT bench top mass spectrometer (Bruker
Daltonics, Bremen, Germany). FlexControl 3.3 and Maldi
Biotyper 3.0 software (Bruker Daltonics) were, respectively,
used for the control of the instrument and for spectra analysis
and comparison with the database (updated with 4613 species).
For calibration purposes, a Bacterial Test Standard (BTS)
provided by themanufacturer was included in every run. Default
settings (acquisition of mass spectra in the linear positive mode
within the 2–20 kDa range, ion source 1 (IS1) 20 kV, IS2
18.05 kV, lens 6.0 kV, linear detector 2560V) were applied.
Direct sample spotting. From each SBE, 8 ml were extracted and
centrifuged at 150 g for 10 min in order to remove blood cells.
The supernatantwas then collected into 1.5-mLmicrocentrifuge
tubes and centrifuged at 14 170 g for 1 min. The pellets from all
the tubes were gathered together into one single tube using
1 mL high-performance liquid chromatography (HPLC)-quality
water (Sigma-Aldrich, St Gallen Rheintal, Switzerland). After
another centrifugation at 14 170 g for 1 min, the supernatant
was discarded and the pellet spotted directly onto a polished
steel MALDI target plate. The sample was allowed to dry at
room temperature and then overlaid with 1 lL of matrix
solution (a-cyano-4-hydroxy-cinnamic acid –a-HCCA solution
in 50% acetonitrile and 2.5% triﬂuoroacetic acid) prepared
following the manufacturer’s instructions. The matrix was
air-dried prior to acquisition of spectra by the mass spectrom-
eter and comparisonwith the database. The turnaround time for
this protocol was 20 min.
Protein extraction step. When a microorganism’s identiﬁcation
was not possible after the direct sample spotting, BCBs were
further tested after a protein extraction step. Brieﬂy, the pellet
obtained with the above-described protocol was resuspended
in 300 lL HPLC-quality water. Subsequently, 900 lL 100%
ethanol were added and the suspension was centrifuged at
14 170 g for 2 min. The supernatant was discarded and the
pellet resuspended in 50 lL of 70% formic acid and the same
amount of 100% acetonitrile. After centrifugation at 14 170 g
for 1 min, 1 lL of the supernatant was spotted onto a polished
steel MALDI target plate and allowed to dry. Then, 1 lL of
matrix solution was added prior to the acquisition of spectra in
a mass spectrometer.
All samples, with and without the protein extraction step,
were tested in duplicate in order to determine the reproduc-
ibility of the method. The ﬁnal score for each sample was the
highest from both measurements. When this method was
performed, the total turnaround time until MALDI-TOF
identiﬁcation was obtained was 30 min per BCB.
Scoring. According to the manufacturer, a score ≥2.0 indicated
species identiﬁcation, a score between 1.7 and 2.0 pointed to
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genus identiﬁcation and a score below 1.7 was not to be
considered as reliable.
Interpretation of results. MALDI-TOF MS results and the
identiﬁcation obtained by conventional methods were corre-
lated as follows: total concordance, MALDI-TOF and conven-
tional methods provided the same identiﬁcation at the species
level; partial concordance, both methods provided a pathogen
identiﬁcation that matched at the genus level; no reliable result,
when MALDI-TOF provided no reproducible identiﬁcation; no
peaks, when no protein spectrum was obtained; discordant
results, when the identiﬁcation obtained by both methods did
not match.
For samples in which more than one pathogen was
detected, results were interpreted as follows: complete iden-
tiﬁcation, MALDI-TOF identiﬁed all the pathogens detected by
conventional methods; partial identiﬁcation, at least one of the
pathogens identiﬁed by conventional methods was not
detected by MALDI-TOF.
Genotypic identiﬁcation
Bacteria cultured from BCBs that provided discordant results
by MALDI-TOF and conventional methods were further
identiﬁed in general by ampliﬁcation of the 5′ end 16S rRNA
gene with the universal primers E8F (5′-AGAGTTTGA
TCCTGGCTCAG-3′) and E533R (5′-TTACCGCGGCTGCT
GGCA-3′) [11]. For streptococci, an internal fragment of
480 bp of the sodA gene was ampliﬁed using degenerated
primers D1 (5′-CCITAYICITAYGAYGCIYTIGARCC-3′) and
D2 (5′-ARRTARTAIGCRTGYTCCCAIACRTC-3′) described
by Poyart et al. [5]. The PCR product was puriﬁed with the
GFX PCR DNA and Gel Band Puriﬁcation kit (GE Healthcare,
Chalfont St Giles, UK) and sequenced using the AbiPrism
3130xl Genetic Analyzer (Applied Biosystems, Carlsbad, CA,
USA). The sequences obtained were compared with those
stored in GeneBank using BLAST alignment software (http://
www.ncbi.nlm.nih.gov/blast) and BIBI (bioInformatic bacterial
identiﬁcation tool, http://pbil.univ-lyon1.fr/bibi). Sequences
were interpreted following the criteria described by Dran-
court et al. [12]. In short, when the homology with reference
strains ranged between 97% and 99%, 16S rRNA and sodA
sequencing allowed the identiﬁcation of the pathogen at the
genus level, and only when the homology was >99% did the
identiﬁcation reach the species level. Results obtained by 16S
rRNA/sodA sequencing were considered the ﬁnal microor-
ganism identiﬁcation.
Ethics statement
The study protocol received institutional review board
approval.
Results
Between August 2011 and January 2013, we evaluated 1000
consecutive episodes of BSI. We took one positive bottle per
patient for MALDI-TOF examination or more than one if
different bacterial Gram stain morphologies were present. Of
them, 932 were monomicrobial infections and 68 were
polymicrobial infections. The analysed BCBs contained overall
1085 microorganisms. The ﬁnal conventional identiﬁcation of
the microorganisms analysed is listed in Table 1.
Results of the MALDI-TOF evaluation by microorganism
From the 1085 microorganisms analysed, MALDI-TOF was
totally concordant (genus and species) with the deﬁnitive
identiﬁcation of 834 microorganisms (76.9%) and partially
concordant (genus level concordance) with 49 microorganisms
(4.5%) (Table 2). No identiﬁcation was obtained for 200
microorganisms (18.4%). Finally, two discordant results were
detected: a Streptococcus sanguinis from a monomicrobial BCB
identiﬁed by MALDI-TOF as Aerococcus viridans and an Escher-
ichia coli identiﬁed by MALDI-TOF as Aeromonas caviae from a
BCB that contained two microorganisms. The Gram staining of
all the identiﬁed microorganisms was in agreement with
MALDI-TOF identiﬁcation, even for misidentiﬁed pathogens.
Out of the 883 microorganisms ﬁnally identiﬁed by
MALDI-TOF, at least at the genus level (81.4%), 190 were
identiﬁed only after the performance of a protein extraction
step (17.5%).
When the manufacturer’s scores were analysed, we
observed that 64 out of the 883 identiﬁed microorganisms
(at least genus level) showed a score below 1.7 (7.2%). On the
other hand, out of the 202 microorganisms discordantly or not
identiﬁed, 200 had a score lower than 1.7 (99%). The analysis
of the microorganisms that MALDI-TOF could not identify
showed that Gram-positive pathogens (54.5%) and yeasts
(24.5%) were harder to identify from BCBs than Gram-neg-
ative microorganisms (20.5%; Table 3).
Results of MALDI-TOF identiﬁcation by patient episode of
BSIs
We also performed an analysis based on the reliability of
MALDI-TOF to anticipate the causative microorganisms in
patients with episodes of BSI.
Out of the 1000 episodes of BSI analysed, 814 (81.4%) were
completely identiﬁed by MALDI-TOF (identiﬁcation of all the
microorganisms present at least at the genus level). Eleven of
these episodes belonged to polymicrobial infections with two
microorganisms present in each. Of the remaining 186
episodes, MALDI-TOF provided a partial identiﬁcation of 51
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TABLE 1. List of the microorganisms identiﬁed by conventional methods and MALDI-TOF
List of microorganisms
identiﬁed by conventional
methods
Number of
isolates
Isolates identiﬁed
by MALDI-TOF
at the species level
Isolates identiﬁed by
MALDI-TOF
at the genus level
Isolates not
identiﬁed by
MALDI-TOF
Abiotropha defectiva 2 2
Acinetobacter baumannii 6 6
Acinetobacter junii 2 2
Acinetobacter lwofﬁ 1 1
Acinetobacter pittii 1 1
Aerococcus urinae 2 2
Aerococcus viridans 1 Discordant ID
Aeromonas caviae 1 Discordant ID
Aeromonas veronii 1 1
Bacillus cereus 8 6 2
Bacillus thurigiensis 1 1
Bacteroides fragilis 4 3 1
Bacteroides thetaiotaomicron 3 3
Bacteroides vulgatus 2 2
Brevundimonas sp. 1 1
Candida albicans 26 1 25
Candida glabrata 6 1 5
Candida krusei 1 1
Candida parapsilosis 12 1 1 10
Candida tropicalis 6 6
Chryseobacterium korensee 1 1
Citrobacter freundii 3 3
Clostridium innocuum 1 1
Clostridium perfringens 5 5
Clostridium ramosum 2 2
Clostridium septicum 1 1
Clostridium sp. 3 3
Corynebacterium sp. 7 7
Enterobacter aerogenes 4 4
Enterobacter agglomerans 2 2
Enterobacter asburiae 6 5 1
Enterobacter cloacae 15 11 4
Enterococcus avium 3 1 2
Enterococcus faecalis 62 59 3
Enterococcus faecium 35 31 4
Enterococcus gallinarum 4 1 3
Enterococcus hirae 1 1
Enterococcus rafﬁnosus 3 2 1
Escherichia coli 213 208 5
Fusobacterium necrophorum 1 1
Fusobacterium nucleatum 2 2
Granulicatella adiacens 2 1 1
Haemophilus inﬂuenzae 3 3
Klebsiella oxytoca 15 11 4
Klebsiella pneumoniae 61 55 6
Lactobacillus rhamnosus 1 1
Lactobacillus sakei 1 1
Leuconostoc mesenteroides 4 2 2
Listeria monocytogenes 4 3 1
Moraxella catarrhalis 1 1
Moraxella atlantae 1 1
Morganella morganii 7 5 2
Mycobacterium fortuitum 1 1
Neisseria meningitidis 1 1
Neisseria sp. 1 1
Paenibacillus urinalis 7 5 2
Parabacteroides distasonis 1 1
Prevotella intermedia 2 2
Prevotella loescheii 1 1
Prevotella melaninogenica 1 1
Proteus mirabilis 19 15 4
Proteus vulgaris 1 1
Providencia stuartii 1 1
Pseudomonas aeruginosa 53 48 5
Raoultella ornithinolytica 1 1
Rhodotorula mucilaginosa 1 1
Rothia dentocariosa 1 1
Rothia mucilaginosa 1 1
Salmonella sp. 16 16
Serratia marcescens 7 7
Staphylococcus aureus 99 68 31
Staphylococcus capitis 2 1 1
Staphylococcus epidermidis 126 101 25
Staphylococcus haemolyticus 5 3 2
Staphylococcus hominis 40 26 8 6
Staphylococcus lugdunensis 1 1
Staphylococcus pettenkoferi 1 1
Staphylococcus simulans 1 1
Staphylococcus warneri 2 1 1
Stenotrophomonas maltophilia 5 3 2
Streptococcus agalactiae 11 9 2
Streptococcus anginosus 1 1
Streptococcus australis 2 2
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polymicrobial episodes (at least one pathogen present in the
BCB was not identiﬁed by MALDI-TOF). In two episodes
MALDI-TOF misidentiﬁed the pathogen present in the BCB
(one corresponding to a polymicrobial infection) and the
remaining 133 episodes (ﬁve polymicrobial) were not reliably
identiﬁed.
Discussion
In this study we have evaluated direct MALDI-TOF MS
identiﬁcation in the routine of a microbiology laboratory. For
that purpose, a large sample collection (1085 microorganisms
from 1000 blood culture bottles) was directly identiﬁed using
MALDI-TOF MS technology. For 81.4% of the microorganisms
detected, MALDI-TOF provided a reliable identiﬁcation at
least at the genus level. The analysis by episode also yielded
81.4% of the BSIs completely identiﬁed at the species or genus
level.
It is well known that a delayed start of adequate
antibiotic treatment increases mortality rates in patients with
Table 1 (Continued)
List of microorganisms
identiﬁed by conventional
methods
Number of
isolates
Isolates identiﬁed
by MALDI-TOF
at the species level
Isolates identiﬁed by
MALDI-TOF
at the genus level
Isolates not
identiﬁed by
MALDI-TOF
Streptococcus constellatus 3 3
Streptococcus dysgalactiae 3 3
Streptococcus gallolyticus 9 9
Streptococcus gordonii 1 1
Streptococcus infantis 1 1
Streptococcus lutetiensis 3 3
Streptococcus mitis 2 1 1
Streptococcus oralis 3 3
Streptococcus parasanguinis 5 5
Streptococcus peroris 1 1
Streptococcus pneumoniae 64 42 10 12
Streptococcus pyogenes 4 3 1
Streptococcus salivarius 6 4 2
Streptococcus sanguinis 3 2 1
Streptococcus thermophilus 1 1
Trichosporon asahii 2 2
Yersinia enterocolitica 1 1
Total 1085 834 (76.8%) 49 (4.5%) 200 (18.4%)
TABLE 2. Microorganisms identiﬁed by MALDI-TOF with
partial concordance with the conventional and molecular
methods
Identiﬁcation by conventional/
molecular methods
Identiﬁcation by
MALDI-TOF
Number of
isolates
Brevundimonas sp. Brevundimonas sp. 1
Candida albicans Candida sp. 1
Candida parapsilosis Candida sp. 1
Clostridium sp. Clostridium sp. 3
Corynebacterium sp. Corynebacterium sp. 7
Neisseria sp. Neisseria sp. 1
Salmonella sp. Salmonella sp. 16
Staphylococcus epidermidis Staphylococcus capitis 1
Staphylococcus epidermidis Staphylococcus hominis 8
Streptococcus pneumoniae Streptococcus mitis/oralis 10
TABLE 3. List of the microorganisms included in the present
study that could not be identiﬁed by MALDI-TOF
Microorganisms
not identiﬁed
by MALDI-TOF
Number of
isolates
Gram-negative microorganisms 41 (20.5%)
Bacteroides fragilis 1
Chryseobacterium korensee 1
Enterobacter agglomerans 2
Enterobacter asburiae 1
Enterobacter cloacae 4
Escherichia coli 5
Fusobacterium nucleatum 2
Klebsiella oxytoca 4
Klebsiella pneumoniae 6
Morganella morganii 2
Prevotella loescheii 1
Prevotella melaninogenica 1
Proteus mirabilis 4
Pseudomonas aeruginosa 5
Stenotrophomonas maltophilia 2
Gram-positive microorganisms 109 (54.5%)
Aerococcus urinae 2
Bacillus cereus 2
Enterococcus avium 2
Enterococcus faecalis 3
Enterococcus faecium 4
Enterococcus gallinarum 3
Enterococcus rafﬁnosus 1
Granulicatella adiacens 1
Leuconostoc mesenteroides 2
Listeria monocytogenes 1
Paenibacillus urinalis 2
Staphylococcus aureus 31
Staphylococcus capitis 1
Staphylococcus epidermidis 25
Staphylococcus haemolyticus 2
Staphylococcus hominis 6
Staphylococcus warneri 1
Streptococcus agalactiae 2
Streptococcus anginosus 1
Streptococcus mitis 1
Streptococcus pneumoniae 12
Streptococcus pyogenes 1
Streptococcus salivarius 2
Streptococcus sanguinis 1
Yeasts 49 (24.5%)
Candida albicans 25
Candida glabrata 5
Candida parapsilosis 10
Candida tropicalis 6
Rhodotorula mucilaginosa 1
Trichosporon asahii 2
Mycobacteria 1 (0.5%)
Mycobacterium fortuitum 1
Total 200
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bacteraemia [2]. The choice of broad-spectrum antibiotics has
negative consequences for both the patient and the
environment. Thus, the early identiﬁcation of the causing
pathogen may lead to a better, more efﬁcient and less
expensive antibiotic treatment.
The implementation of MALDI-TOF MS in the clinical
microbiology laboratory has allowed an accurate identiﬁcation
of a wide variety of bacterial and fungal isolates in recent years
[13–15]. Pathogen identiﬁcation has reached a high rate of
successful identiﬁcation at the species level, ranging between
93% [13] and 84% [15]. Besides, several previous studies have
already demonstrated the efﬁcacy of MALDI-TOF in the
identiﬁcation of pathogens directly from blood cultures
[6,8,9,16]. These studies were performed on smaller collec-
tions of samples and in some cases the aim of the study was to
improve the methodology [6].
However, in our study, the accuracy of MALDI-TOF identi-
ﬁcation has been evaluated on a large collection of clinical
isolates and this technology has been included in theworkﬂowof
a clinical microbiology laboratory. The method has been shown
to be highly reproducible, with 97.9% of the samples identically
identiﬁed in the duplicated spots. The ﬁnal MALDI-TOF
identiﬁcation was obtained within an hour, thus saving at least
one working day and making the identiﬁcation of the pathogens
causing BSI immediately available for clinicians. This fact has been
related to a better outcome of the patient [3,16].
Discrepancies between MALDI-TOF and conventional
identiﬁcation had to be resolved for 131 pathogens. In these
cases, 16S rRNA gene and sodA gene sequencing was
performed and the concordance at the species level between
these techniques and MALDI-TOF was reached in 82 cases
(62.6%). The remaining 49 microorganisms that could only be
identiﬁed by MALDI-TOF at the genus level are listed in
Table 2. In some cases, even the molecular techniques could
not provide identiﬁcation at the species level. In the case of the
Salmonella isolates analysed, MALDI-TOF cannot differentiate
the species belonging to this genus, and thus, the identiﬁcation
provided by MALDI-TOF can only reach the genus level. Thus,
MALDI-TOF ability to identify pathogens directly from BCBs
was superior to the conventional methods and comparable to
molecular techniques. The comparison with the molecular
methods renders MALDI-TOF faster and cheaper, although
16S rRNA and sodA gene sequencing has proved to be a more
speciﬁc technique.
Our study has been designed for the evaluation of
MALDI-TOF reliability in the identiﬁcation of BSI-causing
pathogens, not to assess its clinical impact; that should be
determined in future studies.
Two limitations of MALDI-TOF have been detected: one is
the misidentiﬁcation of different species of the Streptococcus
viridans group as Streptococcus pneumoniae. In our study, this
mistake has been detected in ten cases. In all of them,
MALDI-TOF identiﬁcation was consistent (the top three
identiﬁcation was Streptococcus pneumoniae in all the cases and
the score was above 2.0). However, conventional methods
(Optochin test) and sodA gene sequencing identiﬁed all these
pathogens as members of the Streptococcus viridans group. This
disadvantage of MALDI-TOF has been recently overcome by
Werno et al. [17] as a result of analyzing the mass spectrometry
spectrum: the 2937.5 and 5877 m/z peaks have been found to be
more frequently found in Streptococcus pneumoniae isolates,
whilst these peaks are usually not found in S. mitis and S. oralis
isolates. Thus, the analysis of the mass spectrometry spectra
might clarify the reliability of MALDI-TOF identiﬁcation of a
pathogen as S. pneumoniae. However, further studies are still
needed in order to support the robustness of the spectrum
analysis.
The second limitation observed is the identiﬁcation of
yeasts. It is noteworthy that only one Candida albicans out of
26 included in this study was identiﬁed by MALDI-TOF. The
rest of the analysed yeasts from this genus also were poorly
identiﬁed using MALDI-TOF. Other authors have also
reported that yeasts are not easy to identify with the applied
method. However, either use of the MALDI Sepsityper kit
(Bruker Daltonics, Germany) [18] or the modiﬁcation of the
sample preparation protocol [19] has been demonstrated to
greatly improve the identiﬁcation of different species of
Candida and other yeasts. These modiﬁcations have also been
reported to increase the number of correct identiﬁcations for
Gram-positive microorganisms by incubating the bacterial
pellet with 5% saponin [20] or 5% SDS [21] prior to the
protein extraction step with formic acid and acetonitrile.
Despite the limitations found, MALDI-TOF MS has proved
to be a rapid and reliable method for the identiﬁcation of
pathogens directly from blood culture bottles. The technique
is inexpensive, the identiﬁcation can be obtained within
20–30 min and specialized personnel are not required.
In this study, MALDI-TOF correctly identiﬁed at the species
or genus level 81.4% of the microorganisms tested and only
misidentiﬁed two pathogens. Direct spotting of the isolates
provided a reliable identiﬁcation of 63.9% of isolates (693
microorganisms) obtained within 20 min. Another 190 patho-
gens were also identiﬁed at the same level after the protein
puriﬁcation step. Although MALDI-TOF failed to identify
18.4% of the pathogens analysed, we recommend the direct
spotting method for all BCBs and the protein extraction step
for those isolates with unreliable identiﬁcation. Both methods
can be easily integrated into the workﬂow of a microbiology
laboratory for the identiﬁcation of BSI-causing pathogens
directly from a BCB within a working shift.
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